Public Profile

FNA

FNA, or FNA Pharma Consulting, is a prominent player in the pharmaceutical consulting industry, headquartered in the United States. Founded in 2010, the company has established itself as a trusted partner for pharmaceutical and biotechnology firms, offering expert guidance in regulatory affairs, clinical development, and market access strategies. With a strong operational presence across North America and Europe, FNA is renowned for its tailored solutions that address the unique challenges faced by its clients. The firm’s core services include regulatory submissions, clinical trial management, and strategic market positioning, all designed to enhance product development and commercial success. FNA's commitment to excellence has earned it a solid reputation, making it a go-to resource for companies seeking to navigate the complexities of the pharmaceutical landscape.

DitchCarbon Score

How does FNA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

3

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

6

Industry Benchmark

FNA's score of 3 is lower than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.

26%

FNA's reported carbon emissions

FNA currently does not have available carbon emissions data, as no specific figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This lack of information suggests that FNA may still be in the early stages of developing a comprehensive climate strategy. In the context of the industry, it is increasingly important for companies to establish clear emissions reduction goals and commitments to address climate change effectively. As the global focus on sustainability intensifies, FNA may need to consider setting measurable targets to align with industry standards and expectations.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. FNA's primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. FNA is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

FNA is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Other Organizations in Health Services

Austin Chemical Company

US
Health Services
Updated 10 days ago

Super Beta Glucan Inc.

US
Health Services
Updated 10 days ago

Dermpath Diagnostics

US
Health Services
Updated 3 days ago

Positive Health

US
Health Services
Updated 10 days ago

FinVector

FI
Health Services
Updated 10 days ago

Encube Ethicals Inc

US
Health Services
Updated 3 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers